Article

Aziz Nazha on Adverse Events Associated With Treatment for MDS

Author(s):

Aziz Nazha

Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses adverse events associated with treatment for myelodysplastic syndrome (MDS).

Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses adverse events associated with treatment for myelodysplastic syndrome (MDS).

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Dr. Josh Sabari and Terri Conneran
Dr. Rosario Ligestri
image of man.
Related Content
Image of a head and neck
September 16th 2025

Understanding Head and Neck Cancer: A Guide for Newly Diagnosed Patients

Gina Mauro
illustration of gynecologic cancer
September 16th 2025

What Does An Early-Stage Gynecologic Cancer Diagnosis Mean?

Ryan Scott
Image of blood cells
September 16th 2025

Venclexta And Azacitidine Fail to Improve MDS Survival

Ariana Pelosci
Dr. Paul Gellhaus says PSA testing and modern biopsy methods ease fears and reassure patients, making early prostate cancer detection safe and valuable.
September 16th 2025

Early Prostate Cancer Detection: Why PSA Screening Matters

Dr. Paul Gellhaus
Image of melanoma
September 16th 2025

Early-Stage Melanoma: Diagnosis, Treatment and Next Steps

Ryan Scott
Hypomethylating agents are underutilized, particularly among older, female and non-White patients with MDS: © stock.adobe.com.
September 16th 2025

HMAs Underutilized in Older, Female and Non-White Patients with MDS

Alex Biese